InsidersTradesSigma
Follow the 悦康药业 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 悦康药业 has logged 2 reports. Market capitalisation: €5.4bn. The latest transaction was reported on 21 December 2021 (Sale). Among the most active insiders: 孙健芸. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€21,784
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,465 of 28,752 companies
37.5
score / 100
Value41
Quality34
FCF yld3.8%
Earn yld-4.9%
EV/EBITDA·
ROE-7.7%
Gross mgn50%
Net mgn-11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 December 2021
About 悦康药业
悦康药业 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of innovative medications.